Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 38,997 | 57,353 | 101,259 | 55,873 | 65,495 |
| Depreciation Amortization | 68,637 | 34,026 | 36,006 | 89,603 | 18,821 |
| Income taxes - deferred | -29,558 | -11,810 | -21,132 | -23,561 | 7,097 |
| Accounts receivable | -121,110 | -33,497 | -20,744 | 61,524 | -71,882 |
| Other Working Capital | -19,069 | -68,267 | -11,045 | 37,247 | -86,457 |
| Other Operating Activity | 154,555 | 55,012 | 65,596 | -114,857 | 73,053 |
| Operating Cash Flow | $92,452 | $32,817 | $149,940 | $105,829 | $6,127 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 195,314 | 26,312 | -71,106 | 85,878 | 15,480 |
| PPE Investments | -25,199 | -29,913 | -32,785 | -66,900 | -30,524 |
| Net Acquisitions | -691,348 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | 59,546 | -13,000 | -12,000 | -104,760 | N/A |
| Other Investing Activity | 53,696 | -13,000 | -12,000 | -104,760 | 0 |
| Investing Cash Flow | $-467,537 | $-16,601 | $-115,891 | $-85,782 | $-15,044 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,035,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | -435,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 99,792 | 11,097 | 8,213 | 12,614 | 14,774 |
| Other Financing Activity | -198,931 | 3,317 | 749 | 4,702 | 6,535 |
| Financing Cash Flow | $500,861 | $14,414 | $8,962 | $17,316 | $21,309 |
| Exchange Rate Effect | -298 | -369 | -561 | 380 | 231 |
| Beginning Cash Position | 214,873 | 184,612 | 142,162 | 104,419 | 91,796 |
| End Cash Position | 340,351 | 214,873 | 184,612 | 142,162 | 104,419 |
| Net Cash Flow | $125,478 | $30,261 | $42,450 | $37,743 | $12,623 |
| Free Cash Flow | |||||
| Operating Cash Flow | 92,452 | 32,817 | 149,940 | 105,829 | 6,127 |
| Capital Expenditure | -25,199 | -29,913 | -32,785 | -66,900 | -30,524 |
| Free Cash Flow | 67,253 | 2,904 | 117,155 | 38,929 | -24,397 |